Advanced-stage CD30-positive mycosis fungoides: Clinical experience with brentuximab vedotin

被引：0
|
作者：
Vico-Alonso, Cristina [1 ]
Jose Andres-Lencina, Juan [1 ]
Aragon-Miguel, Raquel [1 ]
Calleja-Algarra, Alba [1 ]
Pinilla-Martin, Belen [1 ]
Sanchez-Velazquez, Alba [1 ]
Munoz-Gonzalez, Hector [1 ]
Penalba, Maria [1 ]
Velasco Tamariz, Virginia [1 ]
Postigo LLorente, Concepcion [2 ]
Ortiz-Romero, Pablo L.
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
16223
引用
收藏
页码：AB173 / AB173
页数：1
相关论文
共 50 条
  • [1] Advanced-Stage CD30+ Mycosis Fungoides Treated With Brentuximab
    Vico-Alonso, C.
    Andres-Lencina, J. J.
    Rodriguez-Peralto, J. L.
    Ortiz Romero, P. L.
    ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (05): : T529 - T531
  • [2] Poikilodermatous mycosis fungoides with CD30-positive large cell transformation successfully treated by brentuximab vedotin
    Popadic, Svetlana
    Lekic, Branislav
    Tanasilovic, Srdjan
    Bosic, Martina
    Nikolic, Milos
    DERMATOLOGIC THERAPY, 2020, 33 (01)
  • [3] Brentuximab vedotin for CD30-positive tumours
    Masuda, Shigeo
    Miyagawa, Shigeru
    Nakamura, Terumi
    Khurram, Maaz Asher
    Sawa, Yoshiki
    LANCET ONCOLOGY, 2016, 17 (09): : E371 - E371
  • [4] Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
    Lesley J. Scott
    Drugs, 2017, 77 : 435 - 445
  • [5] Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
    Scott, Lesley J.
    DRUGS, 2017, 77 (04) : 435 - 445
  • [6] Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
    Borate, Uma
    Mehta, Amitkumar
    Reddy, Vishnu
    Tsai, Michaela
    Josephson, Neil
    Schnadig, Ian
    LEUKEMIA RESEARCH, 2016, 44 : 25 - 31
  • [7] Brentuximab vedotin: unexpectedly good response in CD30- mycosis fungoides
    Sun, J.
    Wang, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (06) : 1300 - 1301
  • [8] Treatment of CD30-Negative Refractory Mycosis Fungoides With Brentuximab Vedotin
    Zhang, Connie
    Chairatchaneeboon, Manasmon
    Haun, Paul
    Landsburg, Daniel
    Kim, Ellen J.
    JAMA DERMATOLOGY, 2018, 154 (01) : 109 - 110
  • [9] A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis
    Gotlib, Jason
    Baird, John H.
    George, Tracy, I
    Langford, Cheryl
    Reyes, Isabel
    Abuel, Justin
    Perkins, Cecelia
    Schroeder, Kurt
    Bose, Prithviraj
    Verstovsek, Srdan
    BLOOD ADVANCES, 2019, 3 (15) : 2264 - 2271
  • [10] Treatment of relapsed/refractory, and advanced stage of mycosis fungoides with brentuximab vedotin (BV): an experience from Kuwait
    Hamed, Rasha
    Hamadah, Abdulaziz
    Alshemmari, Salem
    Abdulazez, Osama
    Nanda, Arti
    Pinto, Karen
    Al Lafi, Atlal
    Rajy, Jihan
    Al-Sabah, Hamoud
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S47 - S47
12345